key: cord-0684969-idjikt4d
authors: Klinakis, Apostolos; Cournia, Zoe; Rampias, Theodoros
title: N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains
date: 2021-10-04
journal: Comput Struct Biotechnol J
DOI: 10.1016/j.csbj.2021.10.004
sha: fe83b9b1e6ecc2b2f99ad3161c99725669d9d19b
doc_id: 684969
cord_uid: idjikt4d

During the past two years, the world has been ravaged by a global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acquired mutations in the SARS-CoV-2 genome affecting virus infectivity and/or immunogenicity have led to a number of novel strains with higher transmissibility compared to the original Wuhan strain. Mutations in the receptor binding domain (RBD) of the SARS-CoV-2 spike protein have been extensively studied in this context. However, mutations and deletions within the N-terminal domain (NTD) located adjacent to the RBD are less studied. Many of these are found within certain β sheet-linking loops, which are surprisingly long in SARS-CoV-2 in comparison to SARS-CoV and other related β coronaviruses. Here, we perform a structural and epidemiological study of novel strains carrying mutations and deletions within these loops. We identify short and long-distance interactions that stabilize the NTD loops of the spike protein and form a critical epitope that is essential for the recognition by a wide variety of neutralizing antibodies from convalescent plasma. Among the different mutations/deletions found in these loops, Ala 67 and Asp 80 mutations as well as His 69/Val 70 and Tyr 144 deletions have been identified in different fast-spreading strains. Similarly, deletions in amino acids 241-243 and 246-252 have been found to affect the network of NTD loops in strains with high transmissibility. Our structural findings provide insight regarding the role of these mutations/deletions in altering the epitope structure and thus affecting the immunoreactivity of the NTD region of spike protein.

provide insight regarding the role of these mutations/deletions in altering the epitope structure and thus affecting the immunoreactivity of the NTD region of spike protein.

SARS-CoV-2, virus evolution, N-terminal domain mutations, immune escape

Evidence before the study The COVID 19 worldwide pandemic is already into the fourth wave, with novel highly aggressive strains expanding rapidly. Mutations in the RBD of the SARS-CoV-2 spike protein have been extensively studied in the context of higher infectability. However, accumulated evidence underlines the critical role of mutations and deletions located in the NTD, in the immunogenicity of the spike protein.

In this study we find that certain loops within the N-terminal domain of the SARS-CoV-2 spike protein have evolutionary diverged in comparison to other beta-coronaviruses and particularly SARS-CoV.

These highly flexible loops are in close proximity and are stabilized by various interactions that stabilize a surface-exposed tertiary structure. A super-epitope recognized by most neutralizing antibodies from convalescent plasma is formed and stabilized by specific amino acid residues within these loops, implying a critical role for epitope structure. For their length, these loops accumulate a disproportionably high number of mutations driving SARS-CoV-2 evolution. Mutations and deletions affecting these amino acid residues are predicted to promote structural changes to the super-epitope region. Such mutations/deletions are common in fast-spreading SARS-CoV-2 strains associated with immune system escape.

Together with available experimental data, our findings implicate mutations and deletions of NTD loop regions in immune evasion, and provide insights into the design of novel antibodies effective against these emerging strains.

Coronaviruses (family: Coronaviridae) are RNA viruses with unusually large genome (~30 Kb), which is of positive or plus-sense (1) . Coronaviruses are divided into four subtypes (α, β, γ and δ) and can infect various hosts from birds to mammals, and cause severe morbidity and mortality. They came under scrutiny in the past two decades due to recurrent incidents of widespread infection of humans. The most common human coronaviruses are the subtypes α 229E and NL63, and subtypes β HKU1 and OC43, which infect the respiratory tract of people throughout the globe causing common cold SARS-CoV and SARS-CoV-2 share almost 80% sequence identity and both enter the host cells through interaction of the S (Spike) protein with the angiotensin-converting enzyme 2 (ACE2) (4) . The Sprotein shares 80% protein similarity between the two SARS strains and binds ACE2 with a similar affinity (5).

It is widely accepted that genetic variability and evolution within the positive strand RNA viruses is mainly driven by the low fidelity of RNA replication as the RNA-dependent RNA polymerase (RdRP) is prone to high error rates (6) . Unlike other RNA viruses, where replication is primarily dependent on the RdRp, in coronaviruses, non-structural proteins (nsps) that include processivity factors (nsp7-8), a helicase (nsp13), a single-strand binding protein (nsp9), a proofreading exonuclease (nsp14) and other cofactors (e.g. nsp 10, nsp16) form a replication complex with the RdRp (that has proof-reading activity and corrects errors by the viral RdRp (7, 8) . As a result, coronaviruses are characterized by a 10-fold lower mutation rate compared to other RNA viruses. Despite the proofreading activity in RNA replication process, the estimated mutation rate for SARS-CoV is 4x10 -4 nucleotide substitutions/site/year (9), while for SARS-CoV-2 it is 1.12 × 10 −3 mutations per site/year (10) .

Recent studies have provided strong evidence that the NTD of SARS-CoV-2 spike protein contains epitopes recognized by neutralizing antibodies produced by host adaptive immune response (11) . Moreover, it has been proposed that this region of the spike protein is dynamically involved in host cell surface adhesion, mediating interactions with glycan groups of cellular glycoenvironment (12) .

Therefore, tracking genetic variation in SARS-CoV-2 NTD is important for monitoring emerging strains with potentially higher capability for immune escape or higher infectivity. In this direction, we investigated the evolution of NTD in β coronaviruses. Comparing the SARS-CoV and SARS-CoV-2 spike structures and analyzing the available mutation data for SARS-CoV-2, we discovered that specific loop elements on NTD that are evolutionary diverged on SARS-CoV-2 clade, display high mutation rates and drive genetic variation. Interestingly, specific mutations and deletions in these loops are associated with an altered NTD structure and affect an epitope region that is common among many different antibodies targeting the NTD region of the spike protein. The corresponding epidemiological data for these mutants revealed that specific NTD mutations and deletions have been positively selected over the last waves of Covid-19 pandemic. Phylogenetic tree generation was performed using the ClustalW2 program.

The COVID-3D online platform (http://biosig.unimelb.edu.au/covid3d/) that implements the Arpeggio program for the calculation of interatomic interactions (14) was used for the visualization of residue interactions between the β3-β4, β9-β10 and β14-β15 loops. This analysis was performed on PDB files corresponding to the cryo-EM structure of SARS-CoV-2 at closed (6VXX) and open (6VSB) state after molecular modelling. According to the provided information by the COVID-3D platform, the structures were optimized by Maestro (https://www.schrodinger.com/maestro, Schrodinger suite, v. 2021-1) generating the PDB structures QHD43416_CLOSED (closed state) and QHD4316_ACE2_BOAT (open state) (15) . Surface electrostatic partial charges were generated with the Poisson-Boltzmann (APBS) method (16) . Visualization of COVID-19 spike protein trajectories was also performed using the BioExcel-CV19 platform designed to provide web-access to atomistic-MD trajectories for macromolecules involved in the COVID-19 disease (https://bioexcel-cv19.bsc.es/#/)

Global mutation data for SARS-CoV-2 NTD sequences were retrieved from the Global Initiative for Sharing All Influenza Data (GISAID) at https://www.gisaid.org/epiflu-applications/phylodynamics/. The frequency over time of SARS-CoV-2 strains harboring mutations on β3-β4, β9-β10 and β14-β15 loops was analyzed through GISAID from January 2020 to July 2021). Nextstrain and WHO nomenclature regarding the major SARS-CoV-2 clades was applied to our analysis for specific variants [23, 24] . 

Ethical approval was unnecessary because this work is a meta-analysis of publicly available data.

The authors received no financial support for this research. To investigate whether the protein alignment of the spike NTD in β coronavirus members displays a similar phylogenetic profile, we performed a comparative sequence analysis among the NTDs of representative β coronaviruses strains. In this direction, residues 15-305 of the SARS-CoV-2 spike protein ( Figure 1A ) were aligned against the NTD sequences of SARS and members of clade 1 (BM48), clade 2 (BM48ZC45, ZXC21) and clade 3 (HKU3, Rp3) Bat-SARS like coronavirus strains. As Figure 1B indicates, the protein alignment of these sequences showed that SARS-CoV-2 and the related batderived strains ZC45 and ZXC21 cluster together, while SARS-CoV and the bat SARS-like sequences cluster separately demonstrating a similar phylogenetic pattern as the one acquired with the genomic sequences.

Integrating the secondary structure elements of SARS-CoV (as identified from the PDB: 5X4S structure)

to this sequence alignment, we observed that overall, the NTD is well conserved within the majority of the β sheets and loops, with the exception of loops separating the β3-β4, β9-β10 and β14-β15 sheets ( Figure 1C ). More specifically, SARS-CoV-2 β3-β4 and β14-β15 loops display an extended length compared to SARS-CoV. While an extended β3-β4 loop is also shared among all bat SARS-CoV members, β14-β15 loop extension is restricted only in SARS-Cov-2. To identify the structural differences in the NTD divergent regions between SARS-CoV-2 and SARS-CoV, the cryo-electron microscopy (EM) structure of SARS-CoV-2 spike protein (18) was compared against the SARS-CoV NTD crystal structure (19) . This structural comparison revealed that the lengths of β3-β4, β9-β10 and β14-β15 loops in SARS-CoV-2 have been evolutionarily extended with regard to SARS-CoV ( Figure 1D ).

Interloop interactions and conformational stability of β3-β4, β9-β10 and β14-β15 domains

According to the cryo-EM structure of the SARS-CoV-2 trimeric spike complex and its proposed conformational states (18, 20) , these loops are highly flexible and exposed on the outer surface of trimeric spike complex, away from the RBD. The protein surface corresponding to these interacting loops is hydrophilic and possesses a positive potential due to the presence of several charged/hydrophilic amino acids ( Figure 2A) . Notably, the β3-β4 and β14-β15 loops (amino acids 62-80 and 242-263, respectively) are in close proximity, stabilized by electrostatic interactions between amino acids in both loops ( Figure 2B ).

Our structural analysis revealed that a network of electrostatic and hydrophobic interactions between several residues of loops β14-β15 and β3-β4 mediate interloop communication. More Figure 5A , B). Therefore, mutations or deletions that affect amino acids in these loops are expected to remodel this epitope and alter the binding affinity of these antibodies. Masking of exposed amino acid residues by glycosylation has been described as a general mechanism of viral immune evasion (25) . It is thus important to mention that two glycosylation sites have been identified in loops β3-β4 and β14-β15, at residues Asn 74 and Asn 149 (26).

3.3. Amino acid variability on β3-β4, β9-β10 and β14-β15 loops modulates the evolutionary dynamics of the NTD region of spike protein in SARS-COV-2 strains

To investigate the distribution of identified SARS-CoV-2 mutations in the NTD secondary structure, mutation data from 2,022,459 high-quality genomic sequences were analyzed through the GISAID SARS-CoV-2 database (https://www.gisaid.org/) as of July 9th, 2021 and aligned to the 1-350 aa sequence of the SARS-CoV-2 spike protein (YP_009724390). We observed that approximately 46.4% of identified NTD non-synonymous mutations in different SARS-CoV-2 strains, are found within the β3-β4, β9-β10 and β14-β15 loop regions, indicating a higher degree of variation in these elements compared to other secondary structure elements within NTD ( Figure 6A -C). Since the β3-β4, β9-β10 and β14-β15

loops are positioned away from the NTD core and the interaction surface with the RBD, mutations therein may be under reduced selective pressure. On the other hand, most of the identified loop variants affect the solvent-accessible surface of the spike protein, and these mutations can potentially affect the dynamics of intermolecular interactions with sugars or antibodies. This is particularly important for RNA viruses, as it is known that high mutation rates on their proteins is associated with escape from host immune response, higher virulence and altered tissue tropism (27) (28) (29) . Interestingly, mutations in the β3-β4 and β9-β10 loops display a higher frequency compared to the β14-β15 one, suggesting a more dynamic role of mutations in these two regions during SARS-CoV-2 evolution.

3.4. Specific mutations within the β3-β4 and β9-β10 loops can lead to conformational changes Since we observed that mutations within the β3-β4 and β9-β10 loops are quite frequent, we sought to investigate whether specific mutations in these regions can modulate the conformational stability of NTD. As mentioned above, our analysis on the 3D structure of the spike protein revealed also known as variants of concern (VOCs) and variants of interest (VOIs), has been established as a response to COVID-19 pandemic and a single Greek letter naming scheme has been adopted by the proposed to drive NTD conformational changes that lead to immune escape from NTD targeting neutralizing antibodies (34) . Moreover, G142D has been shown to alter the binding of NTD targeting antibodies (23) . Notably, A67 and D80 residues in the β3-β4 loop, which we predict to maintain interloop interactions in the NTD supersite, are mutated in Eta (A67V) and Beta (D80A) strains. In line with our analysis, an NTD remodeling induced by D80A has also been proposed recently (35) .

The SARS-CoV-2 virus is genetically related to SARS-CoV, a deadly coronavirus that emerged in late 2002 and caused an outbreak of severe acute respiratory syndrome. SARS-CoV was highly lethal but after intense public health measures, was eradicated in 2003 (36) . The new coronavirus SARS-CoV-2 is less deadly but far more transmissible than SARS-CoV (37) . Moreover, while SARS-CoV appears to infect lung pneumocytes and enterocytes of the small intestine (38), SARS-CoV-2 can infect multiple non-pulmonary organs such as the intestine, liver, kidney and blood vessels (39, 40) .

To identify divergent structure elements on SARS-CoV-2 spike NTD that could potentially modulate interactions with the host, we performed a comparative sequence and structural analysis on SARS-CoV and SARS-CoV-2 NTDs. As expected, spike NTD sequences of SARS-CoV and SARS-CoV-2 are highly similar. The most striking difference is the length of loops β3-β4, β9-β10 and β14-β15 which are significantly longer in the SARS-CoV-2 and in certain bat coronaviruses with genomes closely related to SARS-CoV-2, indicating that the structural evolution of these elements is characteristic for the SARS-CoV-2 clade identity. The low degree of homology between sequences corresponding to the respective loops from bat and human β-coronaviruses, suggests that amino acid variations in these elements have a major impact on divergence of spike proteins within the SARS-CoV-2 clade. Although the cryo-EM data suggest that these divergent loop regions are part of a highly flexible NTD region, our molecular modeling data indicate that a network of electrostatic and hydrophobic interactions between several residues of β3-β4 and β9-β10 loops with residues of the β14-β15 loop mediate an interloop communication that provides a relative stability. Residues Ala 67, His 69 and Asp80 in β3-β4 and Val 143 in the β9-β10 loop were identified to play an important role in these interactions.

It is well accepted that antibodies targeting the RBD confer significantly to the neutralizing activity of convalescent sera (41, 42) . In a recent study however, Voss and colleagues analyzed the proteomic profile of IgGs in convalescent sera and demonstrated that the response is directed predominantly (>80%) against epitopes residing outside the RBD, and include the NTD region and the S2 domain (43) . The same study also reported that anti-NTD antibodies contribute critically to neutralization and their protection is related to their relative levels in plasma.

In this direction, numerous immunological studies have demonstrated that NTD-targeting antibodies elicited in COVID-19 patients are effective neutralizing antibodies (nAbs). In a recent study by Liu and colleagues, almost half of the neutralizing Abs isolated from plasma derived from 40 COVID-19 patients exhibited binding to NTD but not to RBD (24) . Neutralizing antibodies 4A8 (11), COV57 (22), 2-17, 5-24, 4-8 (24) and possibly others (44) target the exposed NTD surface of SARS-CoV-2 spike protein.

Moreover, while RBD-targeting neutralizing antibodies recognize distinct epitopes, various neutralizing antibodies against the NTD target a common site comprising primarily loops β9-β10 and β14-β15 (N3 and N5 according to Chi et al) (21) . It has been postulated that this region is highly immunogenic in part because it is glycan free, which allows epitope recognition. Moreover, the high flexibility of the loops allows the peptide to assume multiple conformations accommodating recognition by several antibodies.

The neutralizing activity of NTD antibodies relies on hindrance which prevents the spike protein from binding to the ACE-2 receptor (21).

It is well accepted that the conformation of epitopes is essential for the neutralizing activity of antibody responses against SARS-CoV (45), whereas specific mutants can escape the neutralizing activity of certain antibodies (46) . Since conformation changes in the β3-β4, β9-β10 and β14-β15 loops could possibly alter NTD antibody recognition, we analyzed the GISAID mutation data in order to study the sequence variation profile of SARS-CoV-2 divergent loops. Our analysis revealed a disproportionate high rate of mutations in these loops indicating a dynamic role in spike sequence divergence and evolution within SARS-CoV-2 clade that could enhance immune escape Regarding the escape from NTD targeting antibodies, strong experimental evidence exists for Alpha and Beta strains (35, (47) (48) (49) , as well as for Delta (50, 51) and Epsilon (34) strains.

This analysis revealed that besides the Gamma strain, all other highly aggressive strains harbor multiple mutations and deletions in β3-β4, β9-β410 and β14-β15 loops. The high prevalence of deletions in these loop regions, may indicate that deletions might be subjected to a stronger selection for antigenic drift than missense mutations.

The structural analysis of complexes between neutralizing antibodies and the NTD suggests that the β9-β410 and β14-β15 loops are closer to the antibody binding surface than the β3-β4 loop, which is not directly involved in interactions with antibody residues. However, our structural analysis, revealed an We acknowledge that all computational data presented here merit further experimental validation. Nevertheless, we have uncovered important aspects regarding virus interaction with the host immune system. Our findings could facilitate the generation of monoclonal antibodies and vaccines with better profile against novel fast-spreading SARS-CoV-2 variants.

All authors designed and performed the analysis. AK and TR wrote the manuscript.

The authors declare that they have no conflict of interest. Modelling and visualization were performed within the COVID-3D Biosig portal. 

Nidovirales: evolving the largest RNA virus genome

COVID-19, SARS and MERS: are they closely related?

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

The role of mutational robustness in RNA virus evolution

The molecular virology of coronaviruses

One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities

Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis

Variant analysis of SARS-CoV-2 genomes

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV

Clustal Omega for making accurate alignments of many protein sequences

Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures

Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource

Electrostatics of nanosystems: application to microtubules and the ribosome

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Distinct conformational states of SARS-CoV-2 spike protein

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Exploitation of glycosylation in enveloped virus pathobiology

Site-specific glycan analysis of the SARS-CoV-2 spike

Why are RNA virus mutation rates so damn high?

RNA replication errors and the evolution of virus pathogenicity and virulence

Porcine respiratory coronavirus differs from transmissible gastroenteritis virus by a few genomic deletions

Viral quasispecies evolution

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic

Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases

SARS-CoV-2 productively infects human gut enterocytes

Multiorgan and Renal Tropism of SARS-CoV-2

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Apostolos Klinakis 1,* , Zoe Cournia 1 and Theodoros Rampias

The authors thank Dr. Rommie Amaro for providing Molecular Dynamics simulations trajectories and structures of the glycan shielded SARS-CoV-2 spike protein and Dr. Modesto Orozco for access to the BioExcel-CV19 platform.

The authors Apostolos Klinakis, Zoe Cournia and Theodoros Rampias declare no conflicts of interest.

N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains